Keqi Chen
3 Papers
Keqi Chen is an academic researcher. The author has contributed to research in topics: Doxorubicin & Antigen. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
In situ injection of dual-delivery PEG based MMP-2 sensitive hydrogels for enhanced tumor penetration and chemo-immune combination therapy
TL;DR: In this article, a nuclear-targeted tetrahedral DNA nanostructure (NLS-TDNs, NT) was synthesized to construct matrix metalloproteinase (MMP-2) sensitive hydrogels as delivery vehicles with co-loaded disulfide cross-linked polyethyleneimine (PSP)/nondetrahedral tetralayer DNA (NT)/doxorubicin (DOX) nanoparticles (NPs) and an immune adjuvant imiquimod (R837) to realize a combination of
48
The management of diabetes mellitus by mangiferin: advances and prospects.
TL;DR: Mangiferin might be a potential adjuvant therapy for the treatment of diabetes mellitus and complications in the future due to its poor aqueous solubility and fatsolubility as well as low bioavailability.
41
Reduction-sensitive polymeric micelles as amplifying oxidative stress vehicles for enhanced antitumor therapy.
Haoran Xia,Yan Liang,Keqi Chen,Chunhua Guo,Mengdi Wang,Jie Cao,Shangcong Han,Qingming Ma,Yong Sun,Bin He +9 more
TL;DR: In this article, a GSH-scavenging and ROS-generating polymeric micelle mPEG-S-S,PCL-Por (MSLP) was designed for amplifying oxidative stress and enhanced anticancer therapy.